Massachusetts Financial Services’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $176M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $53.2M | Sell |
|
|||||
|
2022
Q2 | $184M | Sell |
|
|||||
|
2022
Q1 | $324M | Sell |
|
|||||
|
2021
Q4 | $487M | Sell |
|
|||||
|
2021
Q3 | $560M | Sell |
|
|||||
|
2021
Q2 | $532M | Buy |
|
|||||
|
2021
Q1 | $400M | Buy |
|
|||||
|
2020
Q4 | $343M | Buy |
|
|||||
|
2020
Q3 | $287M | Buy |
|
|||||
|
2020
Q2 | $150M | Buy |
|
|||||
|
2020
Q1 | $74.3M | Buy |
|
|||||
|
2019
Q4 | $36.1M | Buy |
|
|||||
|
2019
Q3 | $30.3M | Buy |
|
|||||
|
2019
Q2 | $24.7M | Buy |
|
|||||
|
2019
Q1 | $22.9M | Sell |
|
|||||
|
2018
Q4 | $20.8M | Sell |
|
|||||
|
2018
Q3 | $33.5M | Buy |
|
|||||
|
2018
Q2 | $22.8M | Buy |
|
|||||
|
2018
Q1 | $13.1M | Buy |
|